Cost-effectiveness of Oral Protease Inhibitors Co-administration versus Pegylated Interferon-Α2b and Ribavirin Only for the Patients with Hepatitis C Genotype 1 in Kazakhstan Health Care Settings

Cost-effectiveness of Oral Protease Inhibitors Co-administration versus Pegylated Interferon-Α2b and Ribavirin Only for the Patients with Hepatitis C Genotype 1 in Kazakhstan Health Care Settings

Background: The triple therapy including peginterferon, ribavirin and protease inhibitors was more effective compared to the combination of only peginterferon and ribavirin. This study aimed to assess the cost-effectiveness of triple treatment in either treatment-naïve and treatment-experienced pat...

Full description

Bibliographic Details
Main Authors: Alima ALMADIYEVA, Serik IBRAYEV, Assiya TURGAMBAYEVA, Alexandr KOSTYUK, Zayituna KHISMETOVA, Zhanar AKHMETOVA
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2018-12-01
Series:Iranian Journal of Public Health
Subjects:
Hepatitis C
Antiviral treatment
Protease inhibitors
Cost-effectiveness
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/15511

Internet

https://ijph.tums.ac.ir/index.php/ijph/article/view/15511

Similar Items